AIRAT A AGBETOBA

Allopathic & Osteopathic Physicians|Anesthesiology HOUSTON, TX NPI 1659639227

General Payments — all program years on this page

$12,003.18

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $11,735.78 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $11,625.006
Food and Beverage $110.786

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Pacira Pharmaceuticals Incorporated $11,703.2810
Merck Sharp & Dohme Corporation $32.502

By program year

Program yearAmountRecords
2019 $20.421
2022 $45.733
2023 $201.256
2024 $11,735.7812

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1141602633 Merck Sharp & Dohme LLC $13.39 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141837496 Merck Sharp & Dohme LLC $19.11 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151238708 Pacira Pharmaceuticals Incorporated $465.00 01/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1151238710 Pacira Pharmaceuticals Incorporated $25.84 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151238712 Pacira Pharmaceuticals Incorporated $10.48 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151238714 Pacira Pharmaceuticals Incorporated $2,480.00 04/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1151238716 Pacira Pharmaceuticals Incorporated $2,480.00 07/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1151238718 Pacira Pharmaceuticals Incorporated $2,480.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1151238720 Pacira Pharmaceuticals Incorporated $27.13 06/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151238722 Pacira Pharmaceuticals Incorporated $14.83 06/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151238724 Pacira Pharmaceuticals Incorporated $2,480.00 10/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1151238726 Pacira Pharmaceuticals Incorporated $1,240.00 12/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.